Skip to main navigation Skip to search Skip to main content

Angiotensin converting enzyme 2 and angiotensin (1-7) axis in pulmonary arterial hypertension

  • Julio Sandoval*
  • , Leonardo del Valle-Mondragón
  • , Felipe Masso
  • , Nayeli Zayas
  • , Tomás Pulido
  • , Ricardo Teijeiro
  • , Hector Gonzalez-Pacheco
  • , Rossana Olmedo-Ocampo
  • , Carlos Sisniega
  • , Araceli Paez-Arenas
  • , Gustavo Pastelin-Hernandez
  • , Jose Gomez-Arroyo
  • , Norbert F. Voelkel
  • *Corresponding author for this work
  • Instituto Nacional de Cardiologia Ignacio Chavez
  • University of Cincinnati
  • Amsterdam UMC - University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

5 Downloads (Pure)

Abstract

Background: In animal models of pulmonary arterial hypertension (PAH), angiotensin-converting enzyme (ACE)2 and angiotensin (Ang)-(1-7) have been shown to have vasodilatory, antiproliferative, antifibrotic and antihypertrophic properties. However, the status and role of the ACE2-Ang(1-7) axis in human PAH is incompletely understood. Methods: We studied 85 patients with a diagnosis of PAH of distinct aetiologies. 55 healthy blood donors paired for age and sex served as controls. Blood samples were obtained from the pulmonary artery in patients with PAH during right heart catheterisation. Peripheral blood was obtained for both groups. Ang (1-7) and -II were measured using zone capillary electrophoresis. Aldosterone, Ang(1-9), AngA and ACE2 were measured using ELISA, and ACE2 activity was determined enzymatically. Results: Of the 85 patients, 47 had idiopathic PAH, 25 had PAH associated with congenital heart disease and 13 had PAH associated with collagen vascular disease. Compared to controls, patients with PAH had a higher concentration of AngII (median 1.03, interquartile range 0.72-1.88 pmol·mL-1 versus 0.19, 0.10- 0.37 pmol·mL-1; p<0.001) and of aldosterone (88.7, 58.7-132 ng·dL-1 versus 12.9, 9.55-19.9 ng·dL-1; p<0.001). Conversely, PAH patients had a lower concentration of Ang(1-7) than controls (0.69, 0.474-0.91 pmol·mL-1 versus 4.07, 2.82-6.73 pmol·mL-1; p<0.001), and a lower concentration of Ang(1-9) and AngA. Similarly, the ACE2 concentration was higher than in controls (8.7, 5.35-13.2 ng·mL-1 versus 4.53, 1.47-14.3 ng·mL-1; p=0.011), whereas the ACE2 activity was significantly reduced (1.88, 1.08-2.81 nmol·mL-1 versus 5.97, 3.1-17.8 nmol·mL-1; p<0.001). No significant differences were found among the three different aetiological forms of PAH. Conclusions: The AngII-ACE2-Ang(1-7) axis appears to be altered in human PAH and we propose that this imbalance, in favour of AngII, plays a role in the pathogenesis of the severe PAH. Further mechanistic studies are warranted.
Original languageEnglish
Article number1902416
JournalEuropean respiratory journal
Volume56
Issue number1
DOIs
Publication statusPublished - 1 Jul 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Angiotensin converting enzyme 2 and angiotensin (1-7) axis in pulmonary arterial hypertension'. Together they form a unique fingerprint.

Cite this